हिंदी में पढ़ें
Income Tax Calculator
Personal Loan Calculator
Car Loan Calculator
Home Loan Calculator
MF Returns Calculator
WHO to decide on Bharat Biotech's Covaxin emergency usage in October
Thu, Sep 30, 2021
The World Health Organisation (WHO) has informed that the final decision on Bharat Biotech`s submission on emergency use listing (EUL) for its Covaxin COVID-19 vaccine will be made in October 2021.
Fully vaccinated person cannot be re-vaccinated: Centre to Kerala HC
Tue, Aug 17, 2021
Central Government has told Kerala High Court that fully vaccinated persons can't be vaccinated again.
DCGI approves study on mixing Covaxin, Covishield- Details here
Wed, Aug 11, 2021
Drugs Controller General of India has given nod for conducting a study on mixing Covaxin and Covishield.
BIG BOOST for Bharat Biotech's Covaxin! Vaccine receives certificate of Good Manufacturing Practices (GMP) from Hungary - Check details
Thu, Aug 05, 2021
A certificate of Good Manufacturing Practice (GMP) compliance has been received by Covaxin from the Hungarian authorities.
Covaxin WHO Approval News: Bharat Biotech Chairman and MD said THIS about WHO Emergency Use Listing - check all details here
Tue, Jul 13, 2021
On Monday, Bharat Biotech said that the company has submitted all documents required for Emergency Use Listing (EUL) of Covaxin to World Health Organisation (WHO) on July 9, 2021.
Covid 19: Decision on emergency use listing of Bharat Biotech's Covaxin likely in 4-6 weeks: WHO
Sat, Jul 10, 2021
The World Health Organization (WHO) is likely to take a decision on including Bharat Biotech's COVID-19 vaccine Covaxin in the emergency use list (EUL) within four to six weeks, Soumya Swaminathan, the global health body's chief scientist has said.
CONFIDENCE BOOSTER! Covaxin 93.4% effective against severe symptomatic COVID-19 cases, 65.2% against new Delta variant, says Bharat Biotech
Sat, Jul 03, 2021
Bharat Biotech has released safety and efficacy analysis data from Phase III clinical trials of COVAXIN®, a whole virion inactivated vaccine against SARS-CoV2.
Bharat Biotech's Covaxin efficacy results in Phase III trials: REVEALED!
Tue, Jun 22, 2021
Bharat Biotech's Covaxin has shown 77.8 percent efficacy after the Subject Expert Committee (SEC) under the drug regulator reviewed its Phase III trials data on Tuesday, according to sources, as per ANI.
DCGI expert panel meet today to review the Phase III data of Bharat Biotech's Covaxin - KEY EXPECTATIONS
Tue, Jun 22, 2021
The Subject Expert Committee (SEC) under the drug regulator will meet on Tuesday, June 22 to review the Phase III data of Bharat Biotech's Covaxin.
Hester has signed a drug substance production agreement with Bharat Biotech: Rajiv Gandhi, CEO & MD
Fri, Jun 18, 2021
Rajiv Gandhi, CEO & Managing Director, Hester Biotech Limited, talks about March quarter performance, Covaxin and tie-up with Bharat Biotech, the international business among others during a chat with Swati Khandelwal, Zee Business.
Covid 19 Vaccines: Covishield vs Covaxin vs Sputnik V - Which one is more EFFECTIVE? Check what experts have to say
Wed, Jun 09, 2021
The nationwide vaccination drive started in India from January 16, 2021. The vaccination started with Covishield and Covaxin. However, recently Russia's Sputnik V vaccine has also been added to the list. Now, in the midst of this scenario, the people are confused regarding which vaccine is better and more effective than the others.
COVID-19 Vaccine Prices in Private Hospitals: After cap announcement by Modi government, THESE RATES are applicable on Covaxin, Covishield and Sputnik V
Wed, Jun 09, 2021
On Tuesday, the Union Ministry has announced price caps for the administration of COVID-19 vaccines in private hospitals.
COVISHIELD vs COVAXIN: Compared! Which one is MORE EFFECTIVE? More antibodies in THIS vaccine? Check study results
Mon, Jun 07, 2021
With the COVID-19 vaccination drive going on across the country, there is a query for which several people are looking for answers. Which COVID-19 vaccine is more effective? Covishield or Covaxin?
Covishield, Covaxin Doses SCHEDULE: CONFUSION CLEARED by NITI AAYOG member Dr Vinod Kumar Paul
Tue, Jun 01, 2021
NITI Aayog Member (Health) Dr. Vinod Kumar Paul has today again repeated that there is absolutely no change in the schedule of Covishield and Covaxin doses. There will be two doses only for both.
Covid-19 vaccine availability in Uttar Pradesh: Covaxin to be made in Bulandshahr soon! 2 crore doses to be manufactured every month
Thu, May 13, 2021
India is currently in the third phase of the nationwide vaccination drive where people above the age of 18 years are getting vaccinated. However, the nation is facing a big shortage in the number of vaccines delivered as demand has surged in the face of rising number of Covid-19 cases.
REVEALED! Covaxin, Covishield, American, Russian and Chinese vaccines price—Cheapest, costliest vaccine details here
Sun, Apr 25, 2021
Covid 19 vaccines price: Bharat Biotech has announced the price of Covid 19 vaccine for state and private hospitals. The decision comes on the directive of the India government. Earlier this week, Serum Institute of India (SII) had also revealed prices of its vaccine.
COVID-19 Update: Bharat Biotech releases third phase trial result, COVAXIN effective up to 81%
Wed, Mar 03, 2021
Indian company Biotech has released the data for the third phase trial of its CORONA vaccine (COVAXIN). It has claimed that the vaccine is 81% effective.
Bharat Biotech: Covaxin phase-3 results show interim efficacy of 81%
Wed, Mar 03, 2021
Bharat Biotech on Wednesday announced the phase 3 results of its coronavirus vaccine ‘Covaxin’ claiming the shots have demonstrated an interim clinical efficacy of nearly 81%.